Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials

Nature Protocols

Volumn 12, Issue 2, 2017, Pages 355-371

  Deloid, Glen M ^a   Cohen, Joel M ^a   Pyrgiotakis, Georgios ^a   Demokritou, Philip ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL;

ADSORPTION KINETICS; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL MODIFICATION; DOSIMETRY; HEALTH HAZARD; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; NANOENGINEERING; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RADIATION DOSE; RADIATION EXPOSURE; STANDARDIZATION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CHEMISTRY; ENGINEERING; NANOTECHNOLOGY; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; ENGINEERING; HUMANS; MODELS, BIOLOGICAL; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 85010952527     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2016.172     Document Type: Article

References (90)

1. Ma, X., Wang, Q., Rossi, L., Ebbs, S.D. & White, J.C. Multigenerational exposure to cerium oxide nanoparticles: physiological and biochemical analysis reveals transmissible changes in rapid cycling Brassica rapa. NanoImpact 1, 46-54 (2016).
2. Pyrgiotakis, G. et al. A chemical free, nanotechnology-based method for airborne bacterial inactivation using engineered water nanostructures. Environ. Sci. Nano 1, 15-26 (2014).
3. Pyrgiotakis, G. et al. Mycobacteria inactivation using engineered water nanostructures (EWNS). Nanomedicine 10, 1175-83 (2014).
4. Pyrgiotakis, G. et al. Inactivation of foodborne microorganisms using engineered water nanostructures (EWNS). Environ. Sci. Technol. 49, 3737-45 (2015).
5. Pyrgiotakis, G. et al. Optimization of a nanotechnology based antimicrobial platform for food safety applications using engineered water nanostructures (EWNS). Sci. Rep. 6, 21073 (2016).
6. Roco, M.C., Mirkin, C.A. & Hersan, M.C. Nanotechnology Research Directions for Societal Needs in 2020, Retrospective and Outlook (Springer, 2011).
7. Servin, A.D. & White, J.C. Nanotechnology in agriculture: next steps for understanding engineered nanoparticle exposure and risk. NanoImpact 1, 9-12 (2016).
8. Sotiriou, G.A. et al. Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential. Environ. Sci. Nano 1, 144-153 (2014).
9. Bott, J., Störmer, A. & Franz, R. A model study into the migration potential of nanoparticles from plastics nanocomposites for food contact. Food Packag. Shelf Life 2, 73-80 (2014).
10. Froggett, S.J., Clancy, S.F., Boverhof, D.R. & Canady, R.A. A review and perspective of existing research on the release of nanomaterials from solid nanocomposites. Part. Fibre Toxicol. 11, 17 (2014).
11. Grassian, V.H. et al. NanoEHS-defining fundamental science needs: no easy feat when the simple itself is complex. Environ. Sci. Nano 3, 15-27 (2016).
12. Konduru, N.V et al. Silica coating influences the corona and biokinetics of cerium oxide nanoparticles. Part. Fibre Toxicol. 12, 31 (2015).
13. Lu, X. et al. In vivo epigenetic effects induced by engineered nanomaterials: a case study of copper oxide and laser printer-emitted engineered nanoparticles. Nanotoxicology 10, 629-39 (2016).
14. Pal, A.K. et al. Linking exposures of particles released from nano-enabled products to toxicology: an integrated methodology for particle sampling, extraction, dispersion, and dosing. Toxicol. Sci. 146, 321-33 (2015).
15. Watson, C. et al. High-throughput screening platform for engineered nanoparticle-mediated genotoxicity using CometChip technology. ACS Nano 8, 2118-33 (2014).
16. Yetisen, A.K. et al. Nanotechnology in textiles. ACS Nano 10, 3042-3068 (2016).
17. Zhou, E.H. et al. Assessing the impact of engineered nanoparticles on wound healing using a novel in vitro bioassay. Nanomedicine (Lond.) 9, 2803-15 (2014).
18. Balbus, J.M. et al. Meeting report: hazard assessment for nanoparticles-report from an interdisciplinary workshop. Environ. Health Perspect. 115, 1654-9 (2007).
19. George, S. et al. Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. ACS Nano 5, 1805-17 (2011).
20. Krewski, D. et al. Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51-138 (2010).
21. Lai, D.Y. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4, 1-15 (2012).
22. Warheit, D.B., Borm, P.J.A., Hennes, C. & Lademann, J. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal. Toxicol. 19, 631-43 (2007).
23. Keller, A.A., McFerran, S., Lazareva, A. & Suh, S. Global life cycle releases of engineered nanomaterials. J. Nanopart. Res. 15, 1692 (2013).
24. Wigger, H. et al. Influences of use activities and waste management on environmental releases of engineered nanomaterials. Sci. Total Environ. 535, 160-71 (2015).
25. Pirela, S.V et al. Development and characterization of an exposure platform suitable for physico-chemical, morphological and toxicological characterization of printer-emitted particles (PEPs). Inhal. Toxicol. 26, 400-8 (2014).
26. Sisler, J.D. et al. Small airway epithelial cells exposure to printer-emitted engineered nanoparticles induces cellular effects on human microvascular endothelial cells in an alveolar-capillary co-culture model. Nanotoxicology 9, 769-79 (2015).
27. Sotiriou, G.A. et al. An integrated methodology for the assessment of environmental health implications during thermal decomposition of nano-enabled products. Environ. Sci. Nano 2, 262-272 (2015).
28. Wohlleben, W. et al. On the lifecycle of nanocomposites: comparing released fragments and their in-vivo hazards from three release mechanisms and four nanocomposites. Small 7, 2384-95 (2011).
29. Pirela, S.V. et al. Effects of intratracheally instilled laser printer-emitted engineered nanoparticles in a mouse model: a case study of toxicological implications from nanomaterials released during consumer use. NanoImpact 1, 1-8 (2016).
30. Pirela, S.V et al. Consumer exposures to laser printer-emitted engineered nanoparticles: a case study of life-cycle implications from nano-enabled products. Nanotoxicology 9, 760-8 (2015).
31. Pirela, S. et al. Effects of copy center particles on the lungs: a toxicological characterization using a Balb/c mouse model. Inhal. Toxicol. 25, 498-508 (2013).
32. Demokritou, P. et al. An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposures. Nanotoxicology 7, 1338-50 (2013).
33. Cohen, J., Deloid, G., Pyrgiotakis, G. & Demokritou, P. Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry. Nanotoxicology 7, 417-31 (2013).
34. Gangwal, S. et al. Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potential. Environ. Health Perspect. 119, 1539-46 (2011).
35. Oberdörster, G. Nanotoxicology: in vitro-in vivo dosimetry. Environ. Health Perspect. 120, A13 author reply A13 (2012).
36. DeLoid, G. et al. Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat. Commun. 5, 3514 (2014).
37. DeLoid, G.M. et al. Advanced computational modeling for in vitro nanomaterial dosimetry. Part. Fibre Toxicol. 12, 32 (2015).
38. Pal, A.K. et al. High resolution characterization of engineered nanomaterial dispersions in complex media using tunable resistive pulse sensing technology. ACS Nano 8, 9003-15 (2014).
39. Teeguarden, J.G., Hinderliter, P.M., Orr, G., Thrall, B.D. & Pounds, J.G. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol. Sci. 95, 300-12 (2007).
40. Bakand, S., Winder, C., Khalil, C. & Hayes, A. Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review. Inhal. Toxicol. 17, 775-87 (2005).
41. Pyrgiotakis, G., Blattmann, C.O. & Demokritou, P. Real-time nanoparticle-cell interactions in physiological media by atomic force microscopy. ACS Sustain. Chem. Eng. 2, 1681-1690 (2014).
42. Pyrgiotakis, G., Blattmann, C.O., Pratsinis, S. & Demokritou, P. Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir 29, 11385-95 (2013).
43. Lundqvist, M. et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5, 7503-7509 (2011).
44. Buford, M.C., Hamilton, R.F. & Holian, A. A comparison of dispersing media for various engineered carbon nanoparticles. Part. Fibre Toxicol. 4, 6 (2007).
45. Sharma, G. et al. Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro. Nanotoxicology 8, 663-75 (2014).
46. Watson, C.Y., DeLoid, G.M., Pal, A. & Demokritou, P. Buoyant nanoparticles: implications for nano-biointeractions in cellular studies. Small 12, 3172-3180 (2016).
47. Cai, W. The optimized fabrication of nanobubbles as ultrasound contrast agents for tumor imaging. Sci. Rep. 5, 13725 (2015).
48. DasSarma, S. et al. An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from Haloarchaea. BMC Biotechnol. 13, 112 (2013).
49. Schmit, V.L., Martoglio, R., Scott, B., Strickland, A.D. & Carron, K.T. Lab-on-a-bubble: synthesis, characterization, and evaluation of buoyant gold nanoparticle-coated silica spheres. J. Am. Chem. Soc. 134, 59-62 (2012).
50. Suzuki, R. & Maruyama, K. Effective in vitro and in vivo gene delivery by the combination of liposomal bubbles (bubble liposomes) and ultrasound exposure. Methods Mol. Biol. 605, 473-86 (2010).
51. Wittmaack, K. Excessive delivery of nanostructured matter to submersed cells caused by rapid gravitational settling. ACS Nano 5, 3766-3778 (2011).
52. Wittmaack, K. Novel dose metric for apparent cytotoxicity effects generated by in vitro cell exposure to silica nanoparticles. Chem. Res. Toxicol. 24, 150-158 (2011).
53. Pal, A.K., Bello, D., Cohen, J. & Demokritou, P. Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials. Nanotoxicology 9, 871-885 (2015).
54. Cohen, J.M., Teeguarden, J.G. & Demokritou, P. An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part. Fibre Toxicol. 11, 20 (2014).
55. Cohen, J.M. et al. Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology 8, 216-25 (2014).
56. Kreyling, W.G. et al. In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J. Nanotechnol. 5, 1699-711 (2014).
57. Anjilvel, S. & Asgharian, B. A multiple-path model of particle deposition in the rat lung. Fundam. Appl. Toxicol. 28, 41-50 (1995).
58. Cassee, F.R. et al. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model. Arch. Toxicol. 76, 277-86 (2002).
59. Geraets, L., Oomen, A.G., Schroeter, J.D., Coleman, V.A. & Cassee, F.R. Tissue distribution of inhaled micro-and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol. Sci. 127, 463-73 (2012).
60. Pirela, S.V et al. Effects of laser printer-emitted engineered nanoparticles on cytotoxicity, chemokine expression, reactive oxygen species, DNA methylation, and DNA damage: a comprehensive in vitro analysis in human small airway epithelial cells, macrophages, and lymphoblasts. Environ. Health Perspect. 124, 210-219 (2016).
61. Powers, K.W., Palazuelos, M., Moudgil, B.M. & Roberts, S.M. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1, 42-51 (2007).
62. Powers, K.W. et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol. Sci. 90, 296-303 (2006).
63. Brown, S.C. et al. Nanoparticle characterization for cancer nanotechnology and other biological applications. Methods Mol. Biol. 624, 39-65 (2010).
64. Brown, S.C. et al. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv. Powder Technol. 18, 69-79 (2007).
65. Crist, R.M. et al. Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory. Integr. Biol. (Camb.) 5, 66-73 (2013).
66. Patri, A. et al. Nanotechnology characterization laboratory: a resource for translational research in nanomedicine. Abstr. Pap. Am. Chem. Soc. 238, COLL 101 (2008).
67. Warheit, D.B. & Donner, E.M. How meaningful are risk determinations in the absence of a complete dataset? Making the case for publishing standardized test guideline and 'no effect' studies for evaluating the safety of nanoparticulates versus spurious 'high effect' results from single investigative studies. Sci. Technol. Adv. Mater. 16, 034603 (2015).
68. Cohen, J.M., DeLoid, G.M. & Demokritou, P. A critical review of in vitro dosimetry for engineered nanomaterials. Nanomedicine (Lond.) 10, 3015-3032 (2015).
69. Schulze, C. et al. Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2, 51-61 (2008).
70. Taurozzi, J.S., Hackley, V.A. & Weisner, M.W. Preparation of Nanoparticle Dispersions from Powdered Material Using Ultrasonic Disruption. NIST Special Publication 1200-2, 1-15 (2012) http://dx.doi.org/10.6028/NIST.SP.1200-2.
71. Taurozzi, J.S., Hackley, V.A. & Wiesner, M.R. Ultrasonic dispersion of nanoparticles for environmental, health and safety assessment-issues and recommendations. Nanotoxicology 5, 711-29 (2011).
72. Taurozzi, J.S., Hackley, V.A. & Wiesner, M.R. A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media. Nanotoxicology 7, 389-401 (2013).
73. Wu, W. et al. Dispersion method for safety research on manufactured nanomaterials. Ind. Health 52, 54-65 (2014).
74. Wohlleben, W. Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J. Nanopart. Res. 14, 1300 (2012).
75. Sterling, M.C., Bonner, J.S., Ernest, A.N.S., Page, C.A. & Autenrieth, R.L. Application of fractal flocculation and vertical transport model to aquatic sol-sediment systems. Water Res. 39, 1818-30 (2005).
76. Carney, R.P. et al. Determination of nanoparticle size distribution together with density or molecular weight by 2D analytical ultracentrifugation. Nat. Commun. 2, 335 (2011).
77. Hinderliter, P.M. et al. ISDD: a computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part. Fibre Toxicol. 7, 36 (2010).
78. Ma, R. et al. Size-controlled dissolution of organic-coated silver nanoparticles. Environ. Sci. Technol. 46, 752-9 (2012).
79. Odzak, N., Kistler, D., Behra, R. & Sigg, L. Dissolution of metal and metal oxide nanoparticles in aqueous media. Environ. Pollut. 191, 132-8 (2014).
80. Kittler, S., Greulich, C., Diendorf, J., Koller, M. & Epple, M. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem. Mater. 22, 4548-4554 (2010).
81. Vasyukova, E., Pokrovsky, O.S., Viers, J. & Dupré, B. New operational method of testing colloid complexation with metals in natural waters. Appl. Geochem. 27, 1226-1237 (2012).
82. Lu, X. et al. Short-term exposure to engineered nanomaterials affects cellular epigenome. Nanotoxicology 10, 140-150 (2015).
83. Ayán-Varela, M. et al. Achieving extremely concentrated aqueous dispersions of graphene flakes and catalytically efficient graphene-metal nanoparticle hybrids with flavin mononucleotide as a high-performance stabilizer. ACS Appl. Mater. Interfaces 7, 10293-307 (2015).
84. Zhang, L. et al. Rationally designed surfactants for few-layered graphene exfoliation: ionic groups attached to electron-deficient π-conjugated unit through alkyl spacers. ACS Nano 8, 6663-70 (2014).
85. Vanhecke, D. et al. Quantification of nanoparticles at the single-cell level: an overview about state-of-the-art techniques and their limitations. Nanomedicine (Lond.) 9, 1885-900 (2014).
86. Demokritou, P. et al. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal. Toxicol. 22, 107-116 (2010).
87. Gass, S. et al. A safer formulation concept for flame-generated engineered nanomaterials. ACS Sustain. Chem. Eng. 1, 843-857 (2013).
88. Sotiriou, G.A. et al. Thermal decomposition of nano-enabled thermoplastics: possible environmental health and safety implications. J. Hazard. Mater. 305, 87-95 (2016).
89. Gauss, C.F. Besprechung des Buchs von L.A. Seeber: Untersuchungen über die Eigenschaften der positiven ternären quadratischen Formen usw. Göttingsche Gelehrt. Anzeigen 2, 188-196 (1831).
90. Song, C., Wang, P. & Makse, H.A. A phase diagram for jammed matter. Nature 453, 629-632 (2008).